ALIRT Research – State of the Underwriting Cycle: Personal Lines At An Inflection Point
A recent article by The Insurer[1] highlighted the findings of a number of large brokers vis-à-vis the state of U.S. property pricing. Mike Rouse, Marsh’s US property practice leader, opined that 2024 would be “a better buying environment again for clients than it was last year and probably than it’s been in the last couple […]
ALIRT Industry Update: U.S. PC Review Three Months 2024
Below we provide first three months of 2024 (3M24) financial highlights for the ALIRT P&C Composite, based on insurers’ statutory financial statements.
ALIRT Industry Update: U.S. Life Review Three Months 2024
Our three month 2024 financial highlights based on insurers’ statutory financial statements.
ALIRT Industry Update: U.S. Health Review Year-End 2023
Our year end 2023 financial highlights based on insurers’ statutory financial statements.
ALIRT Industry Update: U.S. Life Review Year-End 2023
Our year end 2023 financial highlights based on insurers’ statutory financial statements.
ALIRT Industry Update: U.S. PC Review Year-End 2023
Below we provide full year 2023 financial highlights for the ALIRT P&C Composite[1], based on insurers’ statutory financial statements.
ALIRT Industry Update: U.S. PC Review Nine Months 2023
Below we provide first nine months of 2023 (9M23) financial highlights for the ALIRT P&C Composite, based on insurers’ statutory financial statements.
ALIRT Industry Update: U.S. PC Review Six Months 2023
Below we provide first six months of 2023 (6M23) financial highlights for the ALIRT P&C Composite1, based on insurers’ statutory financial statements.
ALIRT Industry Update: U.S. Life Review Six Months 2023
Our six month 2023 financial highlights based on insurers’ statutory financial statements.
ALIRT Industry Update: U.S. Life Review Three Months 2023
Our three month 2023 financial highlights based on insurers’ statutory financial statements.